Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-01-28

Clinical Trial Update: Apremilast Pregnancy Exposure Registry

View source ↗

Summary

This is a pregnancy exposure registry for apremilast. The study is active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • OTEZLA (apremilast)

Snippet

Sponsor: University of California, San Diego | Conditions: Psoriatic Arthritis, Psoriasis | Status: ACTIVE_NOT_RECRUITING